RecruitingPhase 3NCT07185009
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Sanofi
Kingwood, TX · Lubbock, TX · San Antonio, TX · +34 more sites
Ulcerative Colitis clinical trials in San Antonio, TX
15 recruiting ulcerative colitis studies with a site in San Antonio, TX.
All trials in San Antonio, TX · All Ulcerative Colitis trials
RecruitingPhase 2NCT07697456
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Sponsor: AbbVie
Bellaire, TX · Fort Worth, TX · Garland, TX · +57 more sites
RecruitingPhase 3NCT07577856
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Janssen Research & Development, LLC
San Antonio, TX · Tyler, TX · +22 more sites
RecruitingPhase 2NCT07186101
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Sponsor: Eli Lilly and Company
Cedar Park, TX · Dallas, TX · Fort Worth, TX · +37 more sites
RecruitingPhase 2NCT07415044
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Sponsor: Eli Lilly and Company
Fort Worth, TX · Garland, TX · Houston, TX · +49 more sites
RecruitingPhase 2NCT07483073
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Sponsor: Eli Lilly and Company
Kingwood, TX · San Antonio, TX · +12 more sites
RecruitingPhase 3NCT06937086
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Sponsor: Eli Lilly and Company
San Antonio, TX · Tyler, TX · +34 more sites
RecruitingPhase 2NCT07012395
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Sponsor: Spyre Therapeutics, Inc.
Cedar Park, TX · Garland, TX · San Antonio, TX · +23 more sites
RecruitingPhase 3NCT06651281
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Sponsor: Merck Sharp & Dohme LLC
Garland, TX · Lubbock, TX · +9 more sites
RecruitingPhase 2NCT07296315
Confirmatory Clinical Study in Active Ulcerative Colitis
Sponsor: MRM Health NV
San Antonio, TX · +5 more sites
RecruitingPhase 1 / Phase 2NCT06619990
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Sponsor: Xencor, Inc.
Cedar Park, TX · Denton, TX · Garland, TX · +27 more sites
RecruitingPhase 3NCT07196748
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Janssen Research & Development, LLC
Austin, TX · Carrollton, TX · Houston, TX · +53 more sites
RecruitingPhase 4NCT06095128
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Sponsor: Takeda
Dallas, TX · Houston, TX · Mansfield, TX · +34 more sites
RecruitingPhase 3NCT07184996
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Sponsor: Sanofi
Baytown, TX · Dallas, TX · Harlingen, TX · +115 more sites
RecruitingPhase not listedNCT06398626
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Sponsor: Pfizer
Houston, TX · San Antonio, TX · +25 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.